Category: Forbes

Centene CEO: We’re Committed To Buying WellCare

Centene CEO Michael Neidorff is committed to completing the acquisition of WellCare Health Plans with the regulatory process well underway.

Learn To Speak Alzheimer’s

When a loved one is diagnosed with Alzheimer’s disease, it is important to learn how to communicate with them. This article shows examples of how I communicated with my mother who had the disease for 10 years.

Interface Design: Six Ways To Create A Great User Experience

Smart design means providing clear visual cues and a great user experience. Here are some things to keep in mind.

Centene Deal Talk Comes As Humana’s Medicaid Business Grows

Speculation Humana may be interested in acquiring Centene comes as Humana looks to grow its Medicaid business.

Tencent Starts Collecting Medical Data On U.K. Patients In Parkinson’s Trial

Up to 40 patients in London are involved in a clinical trial that is being carried out by Tencent and UK startup Medopad.

Drug-Resistant TB: A Clear And Present Danger

Drug-resistant forms of tuberculosis (DR-TB) have emerged as a major global health threat. A new report by The Economist Intelligence Unit makes a compelling argument for ending this scourge. A new Lancet TB Commission provides a roadmap for ending TB.

Fitter People Have Greatly Reduced Chance Of Developing Lung And Colorectal Cancers, Says New Study

A new study has found that fit people have a dramatically reduced risk of developing lung and colorectal cancer.

How Sunscreen Chemicals Can Get Into Your Blood

Here is what testing by U.S. Food and Drug Administration (FDA) scientists revealed.

Insurers Brace For Pfizer’s $225K Heart Drug And Whether To Pay For It

It’s unclear whether health insurers and PBMs will cover Pfizer’s $225,000 a year drug tafamidis to treat a rare heart disease.

Is AI Data Driven, Algorithm Driven, or Process Driven?

AI is thought to be only data-driven these days. Let’s take a balanced look at AI over time and consider algorithms and process.